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Introduction 
 
The human body comes into contact with numerous unwanted and harmful 
components from the environment, which is inevitable during processes requiring 
environmental connection, such as digestion and respiration. Substances that are foreign 
to an organism are called xenobiotics, these molecules differ greatly in their size and in 
their chemical characteristics. There is a multi-leveled defensive system in order to 
prevent xenobiotics from entering the body, to cope with all the compounds already 
absorbed and to dispose them. Xenobiotic transporters from the ABC transporter protein 
superfamily play a very important role in this protective machinery. 
Ten members of the ABC transporters are known to play a considerable role in 
multidrug resistance of cancer cells, these proteins are the so-called xenobiotic 
transporters. Their common features include extremely broad substrate specificity, 
which has serious consequences in chemotherapy: the presence of xenobiotic 
transporters in tumors increases the resistance of cancer cells against 
chemotherapeutics. Earlier research focused on the roles of these transporters in 
chemotherapy resistance, but recently interesting data have emerged regarding their 
physiological functions. In general, they are involved in normal tissue protection against 
environmental toxins and against endogenous compounds produced in cells during 
normal metabolic processes or in response to stress. 
The epidermis is the largest and most important mechanical and chemical 
permeability barrier in the body. It has been suggested that xenobiotic metabolizing 
enzymes such as cytochrome P450 proteins and xenobiotic transporters contribute to the 
biochemical barrier functions of the epidermis. 
The expression of several xenobiotic transporters has been detected in normal 
human keratinocytes and the membrane associated presence of ABCB1 and ABCC1 has 
also been described in human epidermis. Studies on murine skin showed that xenobiotic 
transporters could affect drug absorption through skin, their distribution and availability 
in the body. 
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Aims 
 
• There is only limited information in the literature about the function of 
xenobiotic transporters in human skin. Our aim was to provide detailed 
transcriptional data on ABCB1 (Pgp/MDR1), ABCC1-6 (MRP1-6) and ABCG2 
(BCRP) genes during proliferation and differentiation of human keratinocytes. 
• Our results on the transcriptional pattern of ABCC4 and ABCG2 genes 
suggested their proliferation-associated expression. Therefore 
o we aimed to investigate the expression of ABCC4 and ABCG2 proteins in 
detail in our in vitro keratinocyte model systems 
o and we decided to examine their role in keratinocyte proliferation using 
siRNA-mediated gene specific silencing and chemical inhibition. 
• Based on our in vitro results we extended our study on ABCC4 and ABCG2 
transporters to human skin, with particular attention to therapeutic 
considerations. 
o We examined the expression of the ABCC4 transporter protein in the skin 
of psoriatic patients. We also aimed to investigate the effect of transporter 
inhibitors and methotrexate – a drug used in the therapy of psoriasis – on 
cultured keratinocytes. 
o We studied the expression of the ABCG2 transporter in non-melanoma 
skin cancers. Our aim was to elucidate the role of ABCG2 as a potential 
target molecule through which the efficacy of PDT can be enhanced. 
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Methods 
 
• Keratinocyte proliferation/differentiation models using HaCaT cells and normal 
human keratinocyte cultures 
• Real-time RT-PCR 
• Western blot and immunocytochemistry were used to determine ABCC4 and 
ABCG2 protein expression 
• Flow cytometric detection of plasma membrane ABCG2 and intracellular 
porphyrin levels 
• siRNA-mediated silencing of ABCC4 and ABCG2 genes 
• 3-(4,5-Dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide (MTT) assay for 
measuring cell viability 
• Real-time cell proliferation analysis (XCELLigence) 
• Immunohistochemical staining to determine ABCC4 and ABCG2 expression in 
tissue samples 
• In vitro photodynamic therapy using HaCaT cells 
 
Results 
 
1. The ABCC4 and ABCG2 transporters are expressed in a proliferation-related 
manner in in vitro models of keratinocyte proliferation and differentiation 
We investigated the expression profile of ABCB1, ABCC1-6 and ABCG2 genes 
during keratinocyte proliferation and differentiation by real-time RT-PCR. Of the 
examined xenobiotic transporter genes, ABCC4 and ABCG2 exhibited a characteristic 
proliferation-related expression pattern in both in vitro models, in synchronized HaCaT 
cells and in differentiating NHKs. The mRNA levels of ABCB1, ABCC1, ABCC3, 
ABCC5 and ABCC6 transporters showed no or only insignificant changes, the ABCC2 
gene was induced only in synchronized HaCaT cells. 
The model of synchronized HaCaT cells is based on a two-week procedure of 
contact inhibition and serum starving, where the cells become highly differentiated and 
cease to proliferate. After passaging and re-adding the serum to the medium the cells 
exit simultaneously from this quiescent state. In parallel with this, the expression of 
differentiation markers decreases, whereas proliferation markers are downregulated. In 
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synchronized HaCaT cells, the ABCC4 and ABCG2 mRNA levels were induced during 
the intensive proliferation of the cells. 
Terminal differentiation of normal human keratinocytes was induced by means 
of contact inhibition and increased Ca2+ concentration. We detected a continuous 
decrease in the expression of ABCC4 and ABCG2 genes during the differentiation of 
the cells. According to our Western blot and immunocytochemistry studies ABCC4 and 
ABCG2 proteins were present at high levels in proliferating cells in both models, 
showing a good correlation with our gene expression data. 
 
2. Inhibition of ABCC-type transporters abrogated the proliferation of normal 
human keratinocytes 
 HaCaT cells and normal human keratinocytes were treated with the ABCC-type 
transporter inhibitor probenecid and the ABCG2 specific inhibitor molecule, Ko-134. 
The proliferation of the cells was monitored real-time during the 72 hour treatment. 
HaCaT cells treated with probenecid or Ko-134 showed a proliferation rate similar to 
control cells. Specific silencing of ABCC4 and ABCG2 genes did not affect the 
viability of HaCaT cells. The disruption of ABCC-type transporter function in normal 
human keratinocytes did not result in cell death, however cell proliferation was 
inhibited by probenecid treatment. Incubation with Ko-134 had no effect on the 
proliferation and viability of normal human keratinocytes. We concluded that ABCC-
type xenobiotic transporters, including ABCC4, could play a significant role in the 
proliferation of normal human keratinocytes. 
 
3. The ABCC4 transporter is overexpressed in hiperproliferating keratinocytes in 
psoriatic lesions 
 Epidermal dendritic cells showed ABCC4 immunopositivity in healthy skin and 
in psoriatic non-lesional skin. However, in psoriatic lesional epidermis basal layer 
keratinocytes expressed the ABCC4 protein at high levels. Our results suggested, that 
the ABCC4 transporter may contribute to abnormal keratinocyte proliferation observed 
in psoriasis. The protein could also modify the efficacy of drugs used in the therapy of 
psoriasis, particularly that of methotrexate. 
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4. ABCC-type transporters play an important role in the resistance of HaCaT cells 
to methotrexate treatment 
 Methotrexate is an antifolate commonly used in the therapy of psoriasis and a 
known substrate of several xenobiotic transporters. HaCaT cells showed significant 
resistance to short-term methotrexate treatment. This phenomenon may be caused by 
xenobiotic transporters expressed in the cells. We applied xenobiotic transporter 
inhibitors during the four-hour methotrexate treatment in order to examine, which 
transporter protein is responsible for methotrexate resistance. The ABCC-type 
transporter inhibitors probenecid and indomethacin significantly increased the toxic 
effect of methotrexate on HaCaT cells. A recently characterized ABCC4 specific 
inhibitor, 4-(2-aminoethyl)-benzenesulfonyl-fluoride exerted a toxic effect on cells, thus 
this molecule is not suitable for further experiments on living cells as a transporter 
inhibitor. 
 
5. The ABCG2 transporter is expressed at high levels in psoriatic lesions and in 
several types of non-melanoma skin cancers 
 A weak staining of the ABCG2 transporter protein was detected in the basal 
layer keratinocytes in healthy skin, while the suprabasal epidermal layers were negative. 
Non-lesional skin of psoriatic patients showed a staining pattern of ABCG2 similar to 
the healthy samples. However, in psoriatic lesional epidermis high levels of ABCG2 
protein was detected in the suprabasal layers. The hyperproliferating basal layer 
keratinocytes showed only very low ABCG2 immunopositivity. These results are in 
accordance with our previous in vitro data, suggesting that the ABCG2 transporter does 
not play a significant role in keratinocyte proliferation. We observed ABCG2 protein 
overexpression in non-melanoma skin cancers. ABCG2 positivity was not characteristic 
to tumor cells in the case of basal cell carcinomas, however, suprabasal layers of the 
epidermis near the lesion showed high level ABCG2 transporter expression. In 
squamous cell carcinoma, Bowen carcinoma, keratoacanthoma and epidermal 
hyperplasia samples the cancerous cells revealed significant ABCG2 positivity. 
 
6. The accumulation of free intracellular porphyrins depends on the expression of 
ABCG2 in HaCaT cells 
We detected a high-level of ABCG2expression in the epidermis of non-
melanoma skin cancer samples, such as basal cell carcinoma and squamous cell 
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carcinoma. Photodynamic therapy is increasingly used as a successful treatment option 
in these skin conditions. It is known that the ABCG2 protein plays an important role in 
removing excess free porphyrins from the cells, therefore we hypothesized that ABCG2 
may be a target molecule to improve the efficacy of photodynamic therapy. We 
characterized an in vitro photodynamic therapy model using HaCaT cells. The cells 
were treated with delta-aminolevulinic acid (DALA), which results in a significant 
increase in intracellular free porphyrin levels. Intracellular porphyrin content of HaCaT 
cells after a four-hour DALA pretreatment was determined by flow cytometry. We 
investigated whether the porphyrin-extruding ability of HaCaT keratinocytes depends 
on the proliferation/differentiation state of the cells. Our previous experiments revealed 
that the ABCG2 protein was nearly undetectable in highly differentiated keratinocytes, 
while high levels of this transporter protein were present in proliferating cells. We next 
examined the correlation between the proliferation/differentiation state of HaCaT 
keratinocytes and porphyrin accumulation. Highly differentiated HaCaT cells 
accumulated ~ 7.5 times more porphyrin than did proliferating cells. Moreover, 
inhibition of the ABCG2 function with Ko-134 during DALA treatment did not result in 
a further increase in porphyrin level in differentiated keratinocytes. The highly 
proliferating cells characterized by elevated levels of the ABCG2 protein displayed a 
significant increase in free porphyrin upon ABCG2 inhibition by Ko-134 during DALA 
pretreatment. 
 
7. Specific inhibition of ABCG2 transporter function increases the efficacy of 
photodynamic treatment in HaCaT cells 
In order to examine the effect of the specific inhibition of ABCG2 function on 
porphyrin-mediated photosensitivity we characterized an in vitro model of 
photodynamic therapy using HaCaT cells. Cells were sensitized by a four-hour DALA 
pretreatment and then irradiated with an Aktilite photodynamic therapy light source. 
DALA pretreatment in combination with Ko-134 significantly and dose-dependently 
increased the sensitivity of HaCaT keratinocytes to irradiation with therapeutic light. 
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Summary 
 
• According to our in vitro studies, ABCC4 and ABCG2 transporters showed a 
proliferation-associated expression pattern in keratinocytes. 
• The ABCC4 transporter may have a regulatory role in keratinocyte proliferation; 
the protein is overexpressed in the hyperproliferating keratinocytes in psoriatic 
lesional skin. 
• ABCC-type xenobiotic transporters – including ABCC4 – contribute to 
methotrexate resistance of HaCaT cells. 
• ABCG2 was highly expressed in non-melanoma skin cancers. 
• The ABCG2 protein removes the photosensitizer porphyrin molecules from the 
cells, and may well be a target molecule to enhance the efficacy of 
photodynamic therapy. 
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